A Phase 2, Randomized, Double Blind, Placebo-Controlled, Multicenter Study to Evaluate Safety, Dosing Schedule and Antibody Kinetics of Recombinant Botulinum Vaccine A/B, rBV A/B-40, in Healthy Adults.
Phase of Trial: Phase II
Latest Information Update: 01 Dec 2011
At a glance
- Drugs Botulism vaccine (Primary)
- Indications Botulism
- Focus Adverse reactions; Pharmacodynamics
- 09 Mar 2011 Follow up of all volunteers has been completed according to a media release published by DynPort Vaccine Company.
- 23 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Apr 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.